Furthermore, an Epstein-Barr virus (EBV)-positive tumor subtype exhibits prominent immune cell infiltration in the tumor microenvironment and genomic features encoding PD-L1, which could make it potentially sensitive to ICB (8). This evidence concerns the gene CD274 and neoplasm.